Status:

Grey

Decision Date:

July 2021

Comments

GREY:

• NICE TA694: Bempedoic acid with Ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia: when a statin is contraindicated or not tolerated, and ezetimibe alone does not control low-density lipoprotein cholesterol well enough. 

(Bempedoic acid - Nilemdo, Bempedoic acid/ezetimibe - Nustendi)

Grey Drug Classifications

• 6: NICE guidance

search again